883 related articles for article (PubMed ID: 20003098)
41. The role of orexin/hypocretin in the central nervous system and peripheral tissues.
Tsunematsu T; Yamanaka A
Vitam Horm; 2012; 89():19-33. PubMed ID: 22640606
[TBL] [Abstract][Full Text] [Related]
42. Hypothalamic prepro-orexin mRNA level is inversely correlated to the non-rapid eye movement sleep level in high-fat diet-induced obese mice.
Tanno S; Terao A; Okamatsu-Ogura Y; Kimura K
Obes Res Clin Pract; 2013; 7(4):e251-7. PubMed ID: 24306152
[TBL] [Abstract][Full Text] [Related]
43. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
[TBL] [Abstract][Full Text] [Related]
44. Fos expression in orexin neurons varies with behavioral state.
Estabrooke IV; McCarthy MT; Ko E; Chou TC; Chemelli RM; Yanagisawa M; Saper CB; Scammell TE
J Neurosci; 2001 Mar; 21(5):1656-62. PubMed ID: 11222656
[TBL] [Abstract][Full Text] [Related]
45. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
46. Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice.
Deng BS; Nakamura A; Zhang W; Yanagisawa M; Fukuda Y; Kuwaki T
J Appl Physiol (1985); 2007 Nov; 103(5):1772-9. PubMed ID: 17717124
[TBL] [Abstract][Full Text] [Related]
47. The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin.
Inutsuka A; Yamanaka A
Nagoya J Med Sci; 2013 Feb; 75(1-2):29-36. PubMed ID: 23544265
[TBL] [Abstract][Full Text] [Related]
48. Arousal effect of orexin A depends on activation of the histaminergic system.
Huang ZL; Qu WM; Li WD; Mochizuki T; Eguchi N; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9965-70. PubMed ID: 11493714
[TBL] [Abstract][Full Text] [Related]
49. The effect of clomipramine on wake/sleep and orexinergic expression in rats.
Feng P; Hu Y; Li D; Vurbic D; Fan H; Wang S; Strohl KP
J Psychopharmacol; 2009 Jul; 23(5):559-66. PubMed ID: 18562438
[TBL] [Abstract][Full Text] [Related]
50. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.
De La Herrán-Arita AK; Zomosa-Signoret VC; Millán-Aldaco DA; Palomero-Rivero M; Guerra-Crespo M; Drucker-Colín R; Vidaltamayo R
Neuroscience; 2011 Jun; 183():134-43. PubMed ID: 21435382
[TBL] [Abstract][Full Text] [Related]
51. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
[TBL] [Abstract][Full Text] [Related]
52. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.
Liu ZW; Gao XB
J Neurophysiol; 2007 Jan; 97(1):837-48. PubMed ID: 17093123
[TBL] [Abstract][Full Text] [Related]
53. Effects of changes in energy homeostasis and exposure of noxious insults on the expression of orexin (hypocretin) and its receptors in the brain.
Machaalani R; Hunt NJ; Waters KA
Brain Res; 2013 Aug; 1526():102-22. PubMed ID: 23830852
[TBL] [Abstract][Full Text] [Related]
54. Hypocretin and its emerging role as a target for treatment of sleep disorders.
Cao M; Guilleminault C
Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
[TBL] [Abstract][Full Text] [Related]
55. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
[TBL] [Abstract][Full Text] [Related]
56. [Connectomics of orexin-producing neurons: analysis using mouse models].
Sakurai T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):223-9. PubMed ID: 22256611
[TBL] [Abstract][Full Text] [Related]
57. Hypocretin/orexin in fish physiology with emphasis on zebrafish.
Panula P
Acta Physiol (Oxf); 2010 Mar; 198(3):381-6. PubMed ID: 19723028
[TBL] [Abstract][Full Text] [Related]
58. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
[TBL] [Abstract][Full Text] [Related]
59. Interactions of orexins/hypocretins with adrenocortical functions.
Kagerer SM; Jöhren O
Acta Physiol (Oxf); 2010 Mar; 198(3):361-71. PubMed ID: 19719797
[TBL] [Abstract][Full Text] [Related]
60. Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal.
Silveyra P; Catalano PN; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E820-8. PubMed ID: 17122088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
